Lonza | LONN - Interest Expense On Debt


Lonza reported CHF84M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 53M 1000K Jun/2026
AstraZeneca USD 371M 31M Sep/2026
BASF EUR 229M 7M Sep/2026
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 14M 6.5M Jun/2026
Covestro EUR 33M 1000K Sep/2025
Demant DKK 424M 26M Jun/2026
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 83M 4M Jun/2026
Geberit CHF 7.4M 300K Dec/2025
Genmab DKK 139M 129M Jun/2026
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 219M 98M Sep/2026
GN Store Nord DKK 286M 10M Jun/2026
Hikma Pharmaceutical USD 67M 47M Dec/2025
Johnson Matthey GBP 75M 4M Jun/2024
Merck EUR 137M 33M Jun/2026
Novartis USD 462M 119M Jun/2026
Philips EUR 83M 26M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 287M 109M Jun/2026
Sika AG CHF 78.9M 100K Dec/2025
Smith & Nephew USD 69M 1000K Dec/2025
Solvay EUR 24M 1000K Jun/2026
UCB EUR 49M 29M Dec/2025